Enanta Pharmaceuticals, Inc. (ENTA)
11.11
-0.17
(-1.51%)
USD |
NASDAQ |
Jun 08, 16:00
11.11
0.00 (0.00%)
After-Hours: 20:00
Enanta Pharmaceuticals Market Cap : 322.87M for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 202.51M |
| MeiraGTx Holdings Plc | 739.94M |
| Keros Therapeutics, Inc. | 197.43M |
| ACADIA Pharmaceuticals, Inc. | 3.714B |
| Alnylam Pharmaceuticals, Inc. | 38.99B |
Market Cap Related Metrics
| PS Ratio | 4.035 |
| Price to Book Value | 2.769 |
| Price | 11.11 |
| Earnings Yield | -23.35% |